These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29869463)

  • 1. A New Integrated Newborn Screening Workflow Can Provide a Shortcut to Differential Diagnosis and Confirmation of Inherited Metabolic Diseases.
    Ko JM; Park KS; Kang Y; Nam SH; Kim Y; Park I; Chae HW; Lee SM; Lee KA; Kim JW
    Yonsei Med J; 2018 Jul; 59(5):652-661. PubMed ID: 29869463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Population-Based Genomic Study of Inherited Metabolic Diseases Detected Through Newborn Screening.
    Park KJ; Park S; Lee E; Park JH; Park JH; Park HD; Lee SY; Kim JW
    Ann Lab Med; 2016 Nov; 36(6):561-72. PubMed ID: 27578510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases.
    Boemer F; Fasquelle C; d'Otreppe S; Josse C; Dideberg V; Segers K; Guissard V; Capraro V; Debray FG; Bours V
    Sci Rep; 2017 Dec; 7(1):17641. PubMed ID: 29247206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of DNA confirmatory and high-risk diagnostic testing for newborns using targeted next-generation DNA sequencing.
    Bhattacharjee A; Sokolsky T; Wyman SK; Reese MG; Puffenberger E; Strauss K; Morton H; Parad RB; Naylor EW
    Genet Med; 2015 May; 17(5):337-47. PubMed ID: 25255367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing based newborn screening and comparative analysis with MS/MS.
    Shen G; Li W; Zhang Y; Chen L
    BMC Pediatr; 2024 Apr; 24(1):230. PubMed ID: 38561707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uncertainty of copy number variants: pregnancy decisions and clinical follow-up.
    Shi P; Liang H; Hou Y; Chen D; Ren H; Wang C; Xia Y; Zhang D; Leigh D; Cram DS; Kong X
    Am J Obstet Gynecol; 2023 Aug; 229(2):170.e1-170.e8. PubMed ID: 36716986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing as a second-tier diagnostic test for newborn screening.
    Luo X; Wang R; Fan Y; Gu X; Yu Y
    J Pediatr Endocrinol Metab; 2018 Aug; 31(8):927-931. PubMed ID: 30030962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project.
    Roman TS; Crowley SB; Roche MI; Foreman AKM; O'Daniel JM; Seifert BA; Lee K; Brandt A; Gustafson C; DeCristo DM; Strande NT; Ramkissoon L; Milko LV; Owen P; Roy S; Xiong M; Paquin RS; Butterfield RM; Lewis MA; Souris KJ; Bailey DB; Rini C; Booker JK; Powell BC; Weck KE; Powell CM; Berg JS
    Am J Hum Genet; 2020 Oct; 107(4):596-611. PubMed ID: 32853555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying targeted next generation sequencing to dried blood spot specimens from suspicious cases identified by tandem mass spectrometry-based newborn screening.
    Qian J; Wang X; Liu J; Zhong J; Le Y; Melchior Tellier LCA; Liu C; Jiang P; Gao R; Wang Y
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):979-988. PubMed ID: 28771436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a Targeted Next-Generation Sequencing Panel for Constitutional Newborn Screening in High-Risk Neonates.
    Lee H; Lim J; Shin JE; Eun HS; Park MS; Park KI; Namgung R; Lee JS
    Yonsei Med J; 2019 Nov; 60(11):1061-1066. PubMed ID: 31637888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing as a follow-up test in an expanded newborn screening programme.
    Smon A; Repic Lampret B; Groselj U; Zerjav Tansek M; Kovac J; Perko D; Bertok S; Battelino T; Trebusak Podkrajsek K
    Clin Biochem; 2018 Feb; 52():48-55. PubMed ID: 29111448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characteristics of newborns with carnitine transporter defect identified by newborn screening in California.
    Gallant NM; Leydiker K; Wilnai Y; Lee C; Lorey F; Feuchtbaum L; Tang H; Carter J; Enns GM; Packman S; Lin HJ; Wilcox WR; Cederbaum SD; Abdenur JE
    Mol Genet Metab; 2017 Nov; 122(3):76-84. PubMed ID: 28711408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical validation of targeted next-generation sequencing for inherited disorders.
    Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
    Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted gene capture next-generation sequencing panel for genetic screening of newborns.
    Peng Q; Liu G; Zhu P; Wu C; He X; Li W; Rao C; Li S; Lu X
    J Pak Med Assoc; 2020 Oct; 70(10):1789-1794. PubMed ID: 33159754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder.
    Maron JL; Kingsmore S; Gelb BD; Vockley J; Wigby K; Bragg J; Stroustrup A; Poindexter B; Suhrie K; Kim JH; Diacovo T; Powell CM; Trembath A; Guidugli L; Ellsworth KA; Reed D; Kurfiss A; Breeze JL; Trinquart L; Davis JM
    JAMA; 2023 Jul; 330(2):161-169. PubMed ID: 37432431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders.
    Mallett AJ; McCarthy HJ; Ho G; Holman K; Farnsworth E; Patel C; Fletcher JT; Mallawaarachchi A; Quinlan C; Bennetts B; Alexander SI
    Kidney Int; 2017 Dec; 92(6):1493-1506. PubMed ID: 28844315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into National Laboratory Newborn Screening and Future Prospects.
    Mujamammi AH
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining newborn metabolic and DNA analysis for second-tier testing of methylmalonic acidemia.
    Peng G; Shen P; Gandotra N; Le A; Fung E; Jelliffe-Pawlowski L; Davis RW; Enns GM; Zhao H; Cowan TM; Scharfe C
    Genet Med; 2019 Apr; 21(4):896-903. PubMed ID: 30209273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of targeted next-generation sequencing in fetuses with congenital heart defect.
    Hu P; Qiao F; Wang Y; Meng L; Ji X; Luo C; Xu T; Zhou R; Zhang J; Yu B; Wang L; Wang T; Pan Q; Ma D; Liang D; Xu Z
    Ultrasound Obstet Gynecol; 2018 Aug; 52(2):205-211. PubMed ID: 29536580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.